← Evidence map

ArticleTranslational cancer research2026

Toward precision immunotherapy in recurrent/metastatic head and neck squamous cell carcinoma: lessons from the FOCUS trial.

Christoph Schultheiss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Toward precision immunotherapy in recurrent/metastatic head and neck squamous cell carcinoma: lessons from the FOCUS trial. | OpenQuestion